What Privia Health Group Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 40 |
| Total trades | 1 | 71 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 71 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Ernest Opella Finley | Director | Sep 01 | Grant / award · A | +6,350 | — | — | 6,350 |
| Mountcastle David | EVP & Chief Financial Officer | Jul 09 | Disclosed 10b5-1 sale · S | −21,275 | $27.67 | −$589K | 164,853 |
| Mountcastle David | EVP & Chief Financial Officer | Jul 07 | Disclosed 10b5-1 sale · S | −600 | $27.57 | −$16.5K | 186,128 |
| Morris Matthew Shawn | Director | Jul 06 | Open-market sale · S | −53,722 | $27.24 | −$1.46M | 68,188 |
| Morris Matthew Shawn | Director | Jul 06 | Exercise / conversion · M | +53,722 | $2.00 | +$107K | 130,373 |
| Mountcastle David | EVP & Chief Financial Officer | Jul 02 | Disclosed 10b5-1 sale · S | −24,734 | $27.50 | −$680K | 186,728 |
| Morris Matthew Shawn | Director | Jul 02 | Open-market sale · S | −59,037 | $27.33 | −$1.61M | 76,651 |
| Morris Matthew Shawn | Director | Jul 02 | Exercise / conversion · M | +59,037 | $2.00 | +$118K | 135,688 |
| Morris Matthew Shawn | Director | Jul 01 | Open-market sale · S | −37,041 | $26.93 | −$998K | 76,651 |
| Morris Matthew Shawn | Director | Jul 01 | Open-market sale · S | −45,634 | $26.52 | −$1.21M | 113,692 |
| Morris Matthew Shawn | Director | Jul 01 | Exercise / conversion · M | +82,675 | $2.00 | +$165K | 159,326 |
| Morris Matthew Shawn | Director | Jun 30 | Open-market sale · S | −52,823 | $25.72 | −$1.36M | 76,651 |
| Morris Matthew Shawn | Director | Jun 30 | Exercise / conversion · M | +52,823 | $2.00 | +$106K | 129,474 |
| Morris Matthew Shawn | Director | Jun 29 | Open-market sale · S | −63,212 | $25.33 | −$1.6M | 76,651 |
| Morris Matthew Shawn | Director | Jun 29 | Exercise / conversion · M | +63,212 | $2.00 | +$126K | 139,863 |
| Mountcastle David | EVP & Chief Financial Officer | Jun 26 | Open-market sale · S | −17,196 | $25.18 | −$433K | 211,462 |
| Mountcastle David | EVP & Chief Financial Officer | Jun 26 | Exercise / conversion · M | +17,196 | $2.00 | +$34.4K | 228,658 |
| Morris Matthew Shawn | Director | Jun 26 | Open-market sale · S | −88,110 | $25.33 | −$2.23M | 76,651 |
| Morris Matthew Shawn | Director | Jun 26 | Exercise / conversion · M | +88,110 | $2.00 | +$176K | 164,761 |
| King David P | Director | May 20 | Grant / award · A | +8,463 | — | — | 50,775 |
Loading...